Table 3.
Adverse event | Grade |
|||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
Cardiovascular | ||||
Lymphedema | 0 | 1 | 0 | 0 |
Constitutional symptoms | ||||
Fatigue | 2 | 8 | 0 | 0 |
Anemia | 0 | 1 | 0 | 0 |
Gastrointestinal | ||||
Anorexia | 1 | 1 | 0 | 0 |
Constipation | 1 | 0 | 0 | 0 |
Diarrhea | 1 | 1 | 1 | 0 |
Abdominal bloating | 1 | 0 | 0 | 0 |
Gastritis | 1 | 0 | 0 | 0 |
Nausea | 2 | 4 | 0 | 0 |
Vomiting | 0 | 1 | 0 | 0 |
Genitourinary | ||||
Urethra injury | 0 | 1 | 0 | 0 |
Ureteral obstruction | 0 | 1 | 0 | 0 |
Fistula – vagina | 0 | 0 | 1 | 0 |
Infection | ||||
Febrile Neutropenia | 0 | 0 | 0 | 0 |
Neutropenia | 0 | 0 | 0 | 0 |
Metabolic/laboratory | ||||
Liver dysfunction – clinical | 0 | 1 | 0 | 0 |
International normalized ratio (INR) of prothrombin time | 1 | 0 | 0 | 0 |
Hyperbilirubinemia | 0 | 0 | 0 | 1 |
Thrombocytopenia | 0 | 0 | 0 | 0 |
Pain | ||||
Abdominopelvic pain | 0 | 5 | 0 | 0 |
Chest Wall arthralgia/myalgia | 3 | 0 | 0 | 0 |
Total | 13 | 25 | 2 | 1 |